Contact

Inhibitors of Sphingolipid Metabolism


857392 (R)-FTY720-OMe

View

857393 THI

View

857395 GT-11

View

860455 N-C12-deoxysphingosine

View

860456 N-C16-deoxysphingosine

View

860461 N-C12-desoxymethylsphinganine

View

860466 N-C12-desoxymethylsphingosine

View

860462 N-C16-deoxysphinganine

View

860463 N-C16-desoxymethylsphinganine

View

860467 N-C16-desoxymethylsphingosine

View

860464 N-C24:1-deoxysphinganine

View

860457 N-C24:1-deoxysphingosine

View

860465 N-C24:1-desoxymethylsphinganine

View

860468 N-C24:1-desoxymethylsphingosine

View

860493 1-deoxysphinganine

View

860470 1-deoxysphingosine

View

860473 1-desoxymethylsphinganine

View

860477 1-desoxymethylsphingosine

View

860479 Adamantanyl Galactosyl(ß) Ceramide

View

860480 C10 bisphosphonate

View

860488 Safingol

View

860771 Enigmol(2S,3S,5S)

View

860772 N-C6-Enigmol(2S,3S,5S)

View

860792 C23 Galactosyl(ß) Ceramide (d18:1/23:0)

View
Sphingolipids are able to exert cell signaling effects. Ceramide is a central component of sphingolipid metabolism that is tightly regulated due to its pro-apoptotic effect. Enzymes involved in the conversion of ceramide to other sphingolipids have been targeted in drug resistance by depleting ceramide to produce pro-survival sphingolipids. Sphingosine kinases, ceramidase, glucosylceramide synthase, and ceramide synthase are all enzymes involved in the metabolism of sphingolipids. Check out Avanti’s wide variety of sphingolipid metabolism inhibitors below!

Lewis, A.C., Wallington-Beddoe, C.T., Powell, J.A., et al. Targeting sphingolipid metabolism as an approach for combination therapies in hematological malignancies. Cell Death Discov. 4, 72 (2018). https://doi.org/10.1038/s41420-018-0075-0